Navigation Links
Kelyniam Global Inc. Reports 2011 3rd & 4th Quarter Financial Results
Date:2/16/2012

CANTON, Conn., Feb. 16, 2012 /PRNewswire/ -- Kelyniam (Pinksheets: KLYG), is pleased to announce the 3rd and 4th quarter 2011 numbers consisting of revenues only derived from the medical device business.

While Kelyniam only received the 510k approval for Custom Skull Implants (CSI) in April of 2011, the company was thrilled to be able to receive and fulfill several orders during the 3rd quarter, even before our commercial launch in September.  Revenues for the 3rd quarter of 2011 were $63,821.  This clearly demonstrates demand for our product.

4th quarter revenues were $46,800.  Fewer surgeries were scheduled around the holidays in December and due to the real-time and custom nature of our products some orders were pushed into the first quarter of 2012.  This resulted in 4th quarter revenues slightly lower than Q3 revenues.   "2011 closes a year of major milestones for Kelyniam.  We look forward to building on the momentum in 2012," said President and CEO Tennyson Anthony.

The unaudited revenues for the 3rd and 4th quarter of 2011 are as follows:Kelyniam Global, IncorporatedCondensed Statement of Income (loss)Dec 31, 2011

Sept 30, 2011OPERATING REVENUERevenues

$
46,800

63,821Cost of revenue

(100,034)

(55,849)Gross profit(53,234)

7,972OPERATING EXPENSEGeneral, administrative and selling expenses

94,057

29,799Professional fees8,412Total operating expense

94,057

38,212OPERATING LOSS

$
(147,291)

(30,240)OTHER INCOME (EXPENSE)Interest expense (net)

(1,259)Loss on sale of securities(1,680)Total other income (expense)

(1,259)

(1,680)NET LOSS(148,550)

(31,920)Other comprehensive loss:

--  Unrealized loss on investment securities

--Total comprehensive income (loss)

(148,550)

(31,920)Shares issued and outstanding

16,022,500

15,822,500Basic(Loss) available to common shareholders per share

$
(0.01)

(0.00)About Kelyniam Global, IncorporatedKelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants to assist medical professionals by allowing them to operate more effectively, improve patient care, and reduce health care costs by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.

Please visit our website at www.kelyniam.com for more information.

Forward-Looking StatementsExcept for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this release, words such as "anticipate," "believes," "estimate," "expect," "should," "intend," "projects," "objective" and "appears" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; the impact of reimbursement rates and coverage; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to revise any forward-looking statements as a result of future events or developments.

For Question regarding this Press Release, please contact:

Kelyniam Global Inc.
Michael Hamblett, 800-280-8192 x3
Director of Investor Relations


'/>"/>

SOURCE Kelyniam Global Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kelyniam Makes History With Revolutionary 24-Hour Turnaround Capabilities
2. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
3. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
4. Directors Forum: PEPFAR and the Global AIDS Response
5. Alfacell Corporation to Present at UBS Global Life Sciences Conference
6. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
7. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
8. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
9. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
10. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
11. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... Md. , June 30, 2017 In ... since the start of May, at least ten diagnostic ... include private investments, public offerings and a loan facility.  ... million to almost $80 million.  Kalorama Information provides a ... of its Diagnostics Knowledge Center. ...
(Date:6/27/2017)... 2017  Therapix Biosciences Ltd. (Nasdaq: TRPX ... the development of cannabinoid-based drugs, today announced that the ... in New York, NY on ... public offering (IPO) of American Depository Shares (ADSs) listed ... Dr. Elran Haber, Ph.D., Chief Executive Officer of ...
(Date:6/20/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal third ... 28, 2017, beginning at 7:30 a.m. (CDT) / 8:30 a.m. ... participate in the conference call, dial (877) 304-8969 (domestic) or ... 10 minutes prior to the start to allow time to ... Webcast: A simultaneous webcast of the call ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... to solve problems and pleads with world leaders to be more open about positive changes. ... peace. He says there is a peaceful and positive way to solve all; yes, all ...
(Date:7/21/2017)... LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based ... the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , The ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... with over 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome ... knee-related quality of life a decade after surgery, though activity levels decline over ...
(Date:7/20/2017)... CA (PRWEB) , ... July 20, 2017 , ... TransPixel ... placed between two clips in the FCPX timeline. This effect isolates horizontal and vertical ... in this package contains either a rotating or flipping animation and can be changed ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... and application performance monitoring (APM) solutions, has expanded its footprint inside the ... According to Peter Ohrenberger, sales director at Nastel, “We’ve replaced an existing ...
Breaking Medicine News(10 mins):